All the news Showing 10 of 327 articles from: United KingdomGet an RSS feed of these articles Show All news infohep newsEditors' picks from other sources Increase in hepatitis (liver inflammation) cases in children under investigation UK Health Security Agency / 13 April 2022 Increase in acute hepatitis of unknown origin among children – United Kingdom ECDC / 13 April 2022 Harm reduction interventions and policy UK report urges re-think on hepatitis C reinfection Keith Alcorn / 11 April 2022 Progress towards the elimination of hepatitis C is being undermined by a lack of attention to the harm reduction needs of people cured of hepatitis C in the United Kingdom, as ... Epidemiology Hepatitis C prevalence down by 40% since 2015 in England Keith Alcorn / 11 March 2022 The prevalence of hepatitis C in England fell by almost 40% between 2015 and 2020 and deaths due to the virus fell by 35% in the same period, the UK Health Security Agency ... Treatment for people who use drugs Prioritise harm reduction services to prevent hepatitis C re-infection, Scottish study finds Keith Alcorn / 24 January 2022 Limiting re-infection with hepatitis C in people who use drugs is most likely to be achieved by intensifying provision of sterile injecting equipment for people using needle and syringe programmes and increasing ... Injecting drug use One in five new cases of hepatitis C in people who inject drugs due to unstable housing, modelling shows Keith Alcorn / 11 January 2022 Unstable housing may be responsible for up to one in five new infections with HIV or hepatitis C among people who inject drugs in the United Kingdom and the United States, a ... Testing for hepatitis C 'Origami' diagnostic test could help hepatitis C treatment Medical Xpress / 13 December 2021 England: Fewer than 700 community pharmacies sign up to provide hepatitis C testing Pharmaceutical Journal / 20 September 2021 Adherence to treatment Ultra-short course treatment for hepatitis C: high failure rate but does not compromise second-line treatment Keith Alcorn / 13 September 2021 Ultra-short treatment courses tailored to a person's pre-treatment viral load deliver lower cure rates than 8-week treatment courses, but failure of ultra-short treatment does not prevent subsequent cure of hepatitis ... Coronavirus US CDC recommends third dose of Moderna or Pfizer COVID-19 vaccines for organ transplant recipients Keith Alcorn / 16 August 2021 People who have undergone a solid organ transplant and who received the Pfizer or Moderna COVID-19 vaccines should receive a third dose, the US Centers for Disease Control and Prevention (CDC) recommended ... ← Prev12345...33Next → Other pages in this section Latest news All the news Hepatitis A Hepatitis B Hepatitis C Hepatitis D Hepatitis E Coronavirus NAFLD Treatment for hepatocellular carcinoma Transmission, epidemiology and prevention Health services, policy and advocacy Social issues Conference news Email bulletin archive